866-997-4948(US-Canada Toll Free)

United States Anticoagulants Market Report 2017

Published By :

QYResearch

Published Date : May 2017

Category :

Pharmaceutical

No. of Pages : 99 Pages

In this report, the United States Anticoagulants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Anticoagulants in these regions, from 2012 to 2022 (forecast).

United States Anticoagulants market competition by top manufacturers/players, with Anticoagulants sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Abbott
Sanofi
Novartis
Pfizer
Merck & Co.
Baxter
Bristol Myers
Bayer
Johnson & Johnson
GlaxoSmithKline

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Oral Anticoagulants
Injectable Anticoagulants (Unfractionated Heparin & Low Molecular Weight Heparin)
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Anticoagulants for each application, including
Thromboembolic Disease
Disseminated Intravascular Coagulation
Cardiovascular Surgery
Others

If you have any special requirements, please let us know and we will offer you the report as you want.
 

Table of Contents

United States Anticoagulants Market Report 2017
1 Anticoagulants Overview
1.1 Product Overview and Scope of Anticoagulants
1.2 Classification of Anticoagulants by Product Category
1.2.1 United States Anticoagulants Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Anticoagulants Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Oral Anticoagulants
1.2.4 Injectable Anticoagulants (Unfractionated Heparin & Low Molecular Weight Heparin)
1.3 United States Anticoagulants Market by Application/End Users
1.3.1 United States Anticoagulants Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Thromboembolic Disease
1.3.3 Disseminated Intravascular Coagulation
1.3.4 Cardiovascular Surgery
1.3.5 Others
1.4 United States Anticoagulants Market by Region
1.4.1 United States Anticoagulants Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Anticoagulants Status and Prospect (2012-2022)
1.4.3 Southwest Anticoagulants Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Anticoagulants Status and Prospect (2012-2022)
1.4.5 New England Anticoagulants Status and Prospect (2012-2022)
1.4.6 The South Anticoagulants Status and Prospect (2012-2022)
1.4.7 The Midwest Anticoagulants Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Anticoagulants (2012-2022)
1.5.1 United States Anticoagulants Sales and Growth Rate (2012-2022)
1.5.2 United States Anticoagulants Revenue and Growth Rate (2012-2022)

2 United States Anticoagulants Market Competition by Players/Suppliers
2.1 United States Anticoagulants Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Anticoagulants Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Anticoagulants Average Price by Players/Suppliers (2012-2017)
2.4 United States Anticoagulants Market Competitive Situation and Trends
2.4.1 United States Anticoagulants Market Concentration Rate
2.4.2 United States Anticoagulants Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Anticoagulants Manufacturing Base Distribution, Sales Area, Product Type

3 United States Anticoagulants Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Anticoagulants Sales and Market Share by Region (2012-2017)
3.2 United States Anticoagulants Revenue and Market Share by Region (2012-2017)
3.3 United States Anticoagulants Price by Region (2012-2017)

4 United States Anticoagulants Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Anticoagulants Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Anticoagulants Revenue and Market Share by Type (2012-2017)
4.3 United States Anticoagulants Price by Type (2012-2017)
4.4 United States Anticoagulants Sales Growth Rate by Type (2012-2017)

5 United States Anticoagulants Sales (Volume) by Application (2012-2017)
5.1 United States Anticoagulants Sales and Market Share by Application (2012-2017)
5.2 United States Anticoagulants Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Anticoagulants Players/Suppliers Profiles and Sales Data
6.1 Abbott
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Anticoagulants Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Abbott Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Sanofi
6.2.2 Anticoagulants Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sanofi Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Novartis
6.3.2 Anticoagulants Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Novartis Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.2 Anticoagulants Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Merck & Co.
6.5.2 Anticoagulants Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Merck & Co. Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Baxter
6.6.2 Anticoagulants Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Baxter Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Bristol Myers
6.7.2 Anticoagulants Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Bristol Myers Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Bayer
6.8.2 Anticoagulants Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bayer Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Johnson & Johnson
6.9.2 Anticoagulants Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Johnson & Johnson Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 GlaxoSmithKline
6.10.2 Anticoagulants Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 GlaxoSmithKline Anticoagulants Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Anticoagulants Manufacturing Cost Analysis
7.1 Anticoagulants Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anticoagulants

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Anticoagulants Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anticoagulants Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Anticoagulants Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Anticoagulants Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Anticoagulants Sales Volume Forecast by Type (2017-2022)
11.3 United States Anticoagulants Sales Volume Forecast by Application (2017-2022)
11.4 United States Anticoagulants Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

 

List of Table

List of Tables and Figures

Figure Product Picture of Anticoagulants
Figure United States Anticoagulants Market Size (K Pcs) by Type (2012-2022)
Figure United States Anticoagulants Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Anticoagulants Product Picture
Figure Injectable Anticoagulants (Unfractionated Heparin & Low Molecular Weight Heparin) Product Picture
Figure United States Anticoagulants Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Anticoagulants by Application in 2016
Figure Thromboembolic Disease Examples
Figure Disseminated Intravascular Coagulation Examples
Figure Cardiovascular Surgery Examples
Figure Others Examples
Figure United States Anticoagulants Market Size (Million USD) by Region (2012-2022)
Figure The West Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anticoagulants Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Anticoagulants Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Anticoagulants Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Anticoagulants Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Anticoagulants Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anticoagulants Sales Share by Players/Suppliers
Figure 2017 United States Anticoagulants Sales Share by Players/Suppliers
Figure United States Anticoagulants Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Anticoagulants Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Anticoagulants Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Anticoagulants Revenue Share by Players/Suppliers
Figure 2017 United States Anticoagulants Revenue Share by Players/Suppliers
Table United States Market Anticoagulants Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Anticoagulants Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Anticoagulants Market Share of Top 3 Players/Suppliers
Figure United States Anticoagulants Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Anticoagulants Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Anticoagulants Product Category
Table United States Anticoagulants Sales (K Pcs) by Region (2012-2017)
Table United States Anticoagulants Sales Share by Region (2012-2017)
Figure United States Anticoagulants Sales Share by Region (2012-2017)
Figure United States Anticoagulants Sales Market Share by Region in 2016
Table United States Anticoagulants Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Anticoagulants Revenue Share by Region (2012-2017)
Figure United States Anticoagulants Revenue Market Share by Region (2012-2017)
Figure United States Anticoagulants Revenue Market Share by Region in 2016
Table United States Anticoagulants Price (USD/Pcs) by Region (2012-2017)
Table United States Anticoagulants Sales (K Pcs) by Type (2012-2017)
Table United States Anticoagulants Sales Share by Type (2012-2017)
Figure United States Anticoagulants Sales Share by Type (2012-2017)
Figure United States Anticoagulants Sales Market Share by Type in 2016
Table United States Anticoagulants Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Anticoagulants Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anticoagulants by Type (2012-2017)
Figure Revenue Market Share of Anticoagulants by Type in 2016
Table United States Anticoagulants Price (USD/Pcs) by Types (2012-2017)
Figure United States Anticoagulants Sales Growth Rate by Type (2012-2017)
Table United States Anticoagulants Sales (K Pcs) by Application (2012-2017)
Table United States Anticoagulants Sales Market Share by Application (2012-2017)
Figure United States Anticoagulants Sales Market Share by Application (2012-2017)
Figure United States Anticoagulants Sales Market Share by Application in 2016
Table United States Anticoagulants Sales Growth Rate by Application (2012-2017)
Figure United States Anticoagulants Sales Growth Rate by Application (2012-2017)
Table Abbott Basic Information List
Table Abbott Anticoagulants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Anticoagulants Sales Growth Rate (2012-2017)
Figure Abbott Anticoagulants Sales Market Share in United States (2012-2017)
Figure Abbott Anticoagulants Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Anticoagulants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Anticoagulants Sales Growth Rate (2012-2017)
Figure Sanofi Anticoagulants Sales Market Share in United States (2012-2017)
Figure Sanofi Anticoagulants Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Anticoagulants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Anticoagulants Sales Growth Rate (2012-2017)
Figure Novartis Anticoagulants Sales Market Share in United States (2012-2017)
Figure Novartis Anticoagulants Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Anticoagulants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Anticoagulants Sales Growth Rate (2012-2017)
Figure Pfizer Anticoagulants Sales Market Share in United States (2012-2017)
Figure Pfizer Anticoagulants Revenue Market Share in United States (2012-2017)
Table Merck & Co. Basic Information List
Table Merck & Co. Anticoagulants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck & Co. Anticoagulants Sales Growth Rate (2012-2017)
Figure Merck & Co. Anticoagulants Sales Market Share in United States (2012-2017)
Figure Merck & Co. Anticoagulants Revenue Market Share in United States (2012-2017)
Table Baxter Basic Information List
Table Baxter Anticoagulants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Baxter Anticoagulants Sales Growth Rate (2012-2017)
Figure Baxter Anticoagulants Sales Market Share in United States (2012-2017)
Figure Baxter Anticoagulants Revenue Market Share in United States (2012-2017)
Table Bristol Myers Basic Information List
Table Bristol Myers Anticoagulants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol Myers Anticoagulants Sales Growth Rate (2012-2017)
Figure Bristol Myers Anticoagulants Sales Market Share in United States (2012-2017)
Figure Bristol Myers Anticoagulants Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Anticoagulants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer Anticoagulants Sales Growth Rate (2012-2017)
Figure Bayer Anticoagulants Sales Market Share in United States (2012-2017)
Figure Bayer Anticoagulants Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Anticoagulants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Anticoagulants Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Anticoagulants Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Anticoagulants Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anticoagulants Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Anticoagulants Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Anticoagulants Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Anticoagulants Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anticoagulants
Figure Manufacturing Process Analysis of Anticoagulants
Figure Anticoagulants Industrial Chain Analysis
Table Raw Materials Sources of Anticoagulants Major Players/Suppliers in 2016
Table Major Buyers of Anticoagulants
Table Distributors/Traders List
Figure United States Anticoagulants Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Anticoagulants Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Anticoagulants Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Anticoagulants Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Anticoagulants Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Anticoagulants Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Anticoagulants Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Anticoagulants Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Anticoagulants Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Anticoagulants Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Anticoagulants Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anticoagulants Sales Volume Share Forecast by Region (2017-2022)
Figure United States Anticoagulants Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *